Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results

Showing results for

Real-time intraoperative depth estimation in transsphenoidal surgery using deep learning: A feasibility study.

Zanier O. et al, (2026), J Clin Neurosci, 147

Committee on Medical Aspects of Radiation in the Environment (COMARE) Twentieth report Risks of cardiovascular disease from exposure to ionising radiation

de Vocht F. et al, (2026)

Generation of biologically responsive colon-like intestinal tissue patches from human induced pluripotent stem cells using a rapid co-differentiation platform.

Dalleywater W. et al, (2026), Stem Cell Res Ther

SET1B Drives Sustained HIF activity and Disease Progression in Clear Cell Renal Cell Carcinoma.

Ortmann BM. et al, (2026), Cancer Res

Deep learning-enhanced data-driven gating improves FDG PET/CT clinical image quality

Wilson Z. et al, (2026), EJNMMI Physics

Survival in Patients With Low Expression of Wild-Type Homologous Recombination Genes: Refining the Homologous Recombination Paradigm in Colorectal Cancer.

Walden D. et al, (2026), JCO Precis Oncol, 10

The vital role of p97/valosin-containing protein-mediated degradation pathways in tumour immunity.

Phyu SM. et al, (2026), Curr Opin Cell Biol, 99

Recent advances in synthetic virtual 3D endoscopy to assist in skull base surgery.

Staartjes VE. et al, (2026), Expert Rev Neurother, 26, 371 - 380

Characterisation of bacteria-induced colitis and its modulation by probiotics in naked mole rats: a new mammalian model for acute inflammatory disease.

Hart DW. et al, (2026), J Pathol, 268, 493 - 511

CMS subtypes correlate with complete response in trial of neoadjuvant Galunisertib plus chemoradiation in rectal cancer.

Rajamanickam V. et al, (2026), Transl Oncol, 66

High-risk molecular features may eclipse genomic complexity in predicting chronic lymphocytic leukemia outcomes; UK clinical trial insights.

Parker H. et al, (2026), Leukemia, 40, 816 - 826

Visualization of Multi-indication Randomized Control Trial Evidence to Support Decision Making in Oncology: A Case Study on Bevacizumab.

Anwer S. et al, (2026), Med Decis Making

Spatial Robustness of Prostate Cancer Biomarkers Evaluated by Spatial Transcriptomics.

Taylor KG. et al, (2026), Prostate

Long-term outcomes of cribriform-positive and cribriform-negative prostate cancer treated with radical prostatectomy in the ProtecT trial.

Sushentsev N. et al, (2026), BJU Int

Liquid biopsy for the diagnosis of EBV-positive Burkitt's lymphoma in endemic areas.

Chamba C. et al, (2026), Nat Med

Factors Affecting Pain Control in Patients with Sickle Cell Disease at Mwananyamala and Muhimbili Hospitals in Dar es Salaam, Tanzania.

Igogo HJ. et al, (2026), J Clin Med, 15

Supplementary Figure S3 from Combined Oxygen-Enhanced MRI and Perfusion Imaging Detect Hypoxia Modification from Banoxantrone and Atovaquone and Track Their Differential Mechanisms of Action

O’Connor JPB. et al, (2026)

Supplementary Figure S6 from Combined Oxygen-Enhanced MRI and Perfusion Imaging Detect Hypoxia Modification from Banoxantrone and Atovaquone and Track Their Differential Mechanisms of Action

O’Connor JPB. et al, (2026)

Supplementary Figure S2 from Combined Oxygen-Enhanced MRI and Perfusion Imaging Detect Hypoxia Modification from Banoxantrone and Atovaquone and Track Their Differential Mechanisms of Action

O’Connor JPB. et al, (2026)

Supplementary Figure S4 from Combined Oxygen-Enhanced MRI and Perfusion Imaging Detect Hypoxia Modification from Banoxantrone and Atovaquone and Track Their Differential Mechanisms of Action

O’Connor JPB. et al, (2026)

Load More

Related blog posts

MSc Precision Cancer Medicine: A Surgeon's Experience

Ee Phui Kew, MBBS, MSc Precision Cancer Medicine (2022-2024) shares insights into the breadth of knowledge he gained from the course and its application in his clinical practice as a thoracic surgeon.

Balancing a Full-Time Research Career and Studying: Insights from an MSc Precision Cancer Medicine Graduate

Sergey Dyshlovoy, Priv.-Doz., PhD, DSc, undertook the MSc in Precision Cancer Medicine in 2022-2024, alongside his full time role as a postdoctoral researcher and becoming a new parent.

More posts